Ellen Kapiteijn - Concepedia

Author

Ellen Kapiteijn

Also Known As

E Kapiteijn, E. Kapiteijn, E. Kapiteijn, E. Klein Kranenbarg, W., E.H. Kapiteijn, Ellen H. Kapiteijn, Ellen H. W. Kapiteijn, Ellen H.W. Kapiteijn, Ellen KAPITEIJN, Ellen Kapiteijn, Ellen W Kapiteijn

475

Publications

16.5K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center The Netherlands Cancer Institute Radboud University Nijmegen University Medical Center Groningen Radboud University Medical Center

About

Ellen Kapiteijn is an author at Leiden University Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	48	5K
2	Health Sciences	11	12	471
3	Cell Biology	4	4	690
4	Public Health	1	1	30
5	Allergy	1	1	189

Ellen Kapiteijn

139

Publications

14.6K

Citations

H-Index

Page 1

	Year	Citations
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, New England Journal of Medicine	2001	4.2K
Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control Irıs D. Nagtegaal, Cornelis J.�H. van de Velde, Erik van der Worp, Journal of Clinical Oncology Surgical OncologyColorectal SurgeryGastroenterologyDiagnosisSurgery	2002	902
Acute Side Effects and Complications After Short-Term Preoperative Radiotherapy Combined With Total Mesorectal Excision in Primary Rectal Cancer: Report of a Multicenter Randomized Trial Corrie A.M. Marijnen, Ellen Kapiteijn, Cornelis J.�H. van de Velde, Journal of Clinical Oncology	2002	589
Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands Ellen Kapiteijn, Hein Putter, Cornelis J.�H. van de Velde British journal of surgery	2002	477
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, New England Journal of Medicine	2022	474
Neoantigen landscape dynamics during human melanoma–T cell interactions Els M.E. Verdegaal, Noel F.C.C. de Miranda, Marten Visser, Nature MelanomaTumor ImmunityNeoantigen Landscape DynamicsMedicineCell Biology	2016	453
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial A.J. Breugom, W. van Gijn, E.W. Muller, Annals of Oncology Rectal Cancer PatientsSurgical OncologyRadiation TherapyGastrointestinal OncologyColorectal Surgery	2014	383
Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 <sup>+</sup> T cell response Pia Kvistborg, Daisy Philips, Sander Kelderman, Science Translational Medicine	2014	369
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi, Nature Medicine Surgical OncologyOncologyPrado TrialMelanomaClinical Trials	2022	322
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, Cancer Immunology Immunotherapy MedicineLactate DehydrogenaseMelanomaPharmacologyIpilimumab Treatment	2014	299

Page 1